European Oncology and Haematology : Impact Factor & More
eISSN: 2045-5283pISSN: 2045-5275
Share this on:
Key Metrics
CiteScore 
0.5
H-Index
8
SJR
Q4Oncology
SNIP
0.12
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
European Oncology and Haematology Journal Specifications
Indexed in the following public directories
SJR
| Overview | |
| Publisher | Touch Digital Media |
Planning to publish in European Oncology and Haematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European Oncology and Haematology
Immunotherapy in Advanced Prostate Cancer
- 1 Jan 2020
- European Oncology & Haematology
ALK Inhibitors in ALK-positive NSCLC with Central Nervous System Metastases
- 1 Jan 2020
- European Oncology & Haematology
Development of<i>HER2</i>-targeted Therapies for Gastrointestinal Cancer
- 1 Jan 2020
- European Oncology & Haematology
Thromboprophylaxis – A Neglected Front in Hospitalised Patients with COVID-19 in Pakistan
- 1 Jan 2020
- European Oncology & Haematology
Facing the First-line in Metastatic Non-small-cell Lung Cancer – Immunotherapy and Chemotherapy
- 1 Jan 2020
- European Oncology & Haematology
Regorafenib – Five Years in Review
- 1 Jan 2020
- European Oncology & Haematology
Immunotherapy in Advanced Prostate Cancer
- 1 Jan 2020
- European Oncology & Haematology
ALK Inhibitors in ALK-positive NSCLC with Central Nervous System Metastases
- 1 Jan 2020
- European Oncology & Haematology
Development of<i>HER2</i>-targeted Therapies for Gastrointestinal Cancer
- 1 Jan 2020
- European Oncology & Haematology
Thromboprophylaxis – A Neglected Front in Hospitalised Patients with COVID-19 in Pakistan
- 1 Jan 2020
- European Oncology & Haematology
Facing the First-line in Metastatic Non-small-cell Lung Cancer – Immunotherapy and Chemotherapy
- 1 Jan 2020
- European Oncology & Haematology
Regorafenib – Five Years in Review
- 1 Jan 2020
- European Oncology & Haematology
FAQs on European Oncology and Haematology
How many articles did European Oncology and Haematology publish last year? 
What is the eISSN & pISSN for European Oncology and Haematology?
What is Citescore for European Oncology and Haematology?
What is the H Index for European Oncology and Haematology ?
What is SNIP score for European Oncology and Haematology?
What is the SJR for European Oncology and Haematology?
Who is the publisher of European Oncology and Haematology?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations